Big pharma company Eli Lilly (NYSE: LLY ) faces allegations of bribing medical doctors in China, just weeks after similar claims arose against its peers GlaxoSmithKline and Sanofi. In the following video, taken from The Motley Fool's health-care show, analysts David Williamson and Max Macaluso discuss this story and the potential impact of these claims on investors.
Take a moment to look past these recent scandals, and you'll see that one of the best parts of owning big pharma stocks is their attractive dividends. But smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.